UTMB Clinical and Translational Science Award
UTMB 临床和转化科学奖
基本信息
- 批准号:9270638
- 负责人:
- 金额:$ 26.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-18 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:Academic TrainingAddressAssessment toolAwardBasic ScienceBehavior TherapyClinicalClinical ResearchClinical SciencesClinical TrialsCommunicationCompetenceDevicesDiagnosticDisciplineDiseaseDoctor of PhilosophyEducational CurriculumEnrollmentEntrepreneurshipEthical IssuesFacultyFellowshipFundingFutureGoalsHealthHumanHuman Subject ResearchHybridsIndustryInterventionKnowledgeLaboratoriesLeadershipLettersMediationMedical StudentsMentorsMethodsModelingPharmaceutical PreparationsPositioning AttributePostdoctoral FellowProgram EvaluationRecruitment ActivityResearchResearch ActivityResearch DesignResearch InfrastructureResearch Project GrantsResearch TrainingResourcesRotationSchoolsScienceStudent recruitmentStudentsTNFSF15 geneTechnical ExpertiseTestingTherapeuticTrainingTraining ProgramsTraining SupportTranslational ResearchUnderrepresented MinorityWorkWorkforce Developmentbaseconflict resolutiongraduate studentimprovedinnovationmultidisciplinarypre-doctoralprogramsscience educationskillssuccess
项目摘要
ABSTRACT
This TL1 Training Core, in support of the UTMB CTSA U54 application, will provide “predoctoral students (3
trainees/year) with a deep orientation to translational science, and postdoctoral fellows (3 scholars/year) with
advanced research training aligned with the CTSA's goals of advancing therapeutics (drugs, devices,
diagnostics and preventatives), clinical interventions, and behavioral modifications to improve human health.”
Existing curricula and training programs at UTMB, as elsewhere, excel at developing discipline-specific
knowledge and technical skills, but are less effective at developing the core skills and competencies essential
for the effective and efficient practice of team-based translational science; these are: team management,
shared leadership, conflict resolution and negotiations, interprofessional communication, entrepreneurship, and
the regulatory and ethical issues associated with human subjects research and clinical trials. To address this
gap, we will build on our CTSA hub's successful application of a hybrid industry “work team”-academic
approach to translational research using a Multidisciplinary Translational Team (MTT) model. We will also use
a training model that is based on our successful implementation of a competency-driven curriculum for a new
translational PhD program. We will recruit from a sufficiently large pool of trainees in any of our 13 biomedical
graduate programs, including a large proportion of underrepresented minorities, which is mirrored by a diverse
faculty. Of key importance, the GSBS and the UTMB Provost initiated and fund financial supplements for
students recruited as Presidential Scholars to encourage the enrollment of outstanding graduate students.
Potential trainees will be advised to pursue laboratory rotations with MTT-based faculty. Once a mentoring
team is selected, students and their mentors will apply for training positions (predoctoral fellowship) in the TL1
Training Core. Postdoctoral scholars will be specifically recruited to the program by MTT-based mentors
(Program Faculty). Among others, three particularly innovative components of the required curriculum include:
1) the Interprofessional Translational Research Design Course, which includes medical students and PhD
students working in teams; 2) the Clinical Encounters Program, which addresses the need for trainees and
scholars to be educated in the human health- and disease-related aspects of their research; and 3)
dissertation/postdoctoral research projects co-mentored by both scientific and clinical experts. Lastly, our
training program's evaluations will use relevant, validated assessment tools such as the Teamwork
Competency Test and others. Primary financial resources, space, and staff are committed by UTMB to provide
oversight, key core resources, integrative programs and seminars for this Training Core. The Graduate School
of Basic Sciences also provides financial and infrastructure support for the Training Core. Lastly, the
supporting letter from the UTMB Provost enumerates the current and future commitments to the ITS, which
assure the success of this oversight entity for our innovative training program.
抽象的
该 TL1 培训核心支持 UTMB CTSA U54 申请,将提供“博士前学生(3
学员/年)对转化科学有深入的了解,博士后研究员(3名学者/年)
高级研究培训与 CTSA 推进治疗学(药物、设备、
诊断和预防)、临床干预和行为改变,以改善人类健康。”
与其他地方一样,UTMB 现有的课程和培训计划擅长开发特定学科
知识和技术技能,但在发展必要的核心技能和能力方面效果较差
为了有效和高效地实践基于团队的转化科学;
共同领导、冲突解决和谈判、跨专业沟通、创业精神和
与人体研究和临床试验相关的监管和伦理问题。
差距,我们将在 CTSA 中心成功应用混合行业“工作团队”-学术的基础上继续发展
我们还将使用多学科转化团队(MTT)模型进行转化研究。
一种基于我们成功实施能力驱动课程的培训模式
我们将从 13 个生物医学项目中的任何一个中招募足够多的学员。
研究生课程,其中包括很大一部分代表性不足的少数族裔,这反映在多样化的
至关重要的是,GSBS 和 UTMB 教务长发起并资助了教师的财政补贴。
招收学生为总统学者,鼓励优秀研究生招生。
一旦接受指导,潜在的学员将被建议与 MTT 教师一起进行实验室轮换。
团队选定后,学生及其导师将申请 TL1 的培训职位(博士前奖学金)
培训核心。博士后学者将由基于 MTT 的导师专门招募到该项目。
(项目教师)。除其他外,所需课程的三个特别创新的组成部分包括:
1)跨专业转化研究设计课程,包括医学生和博士生
学生团队合作;2) 临床遭遇项目,满足学员的需求;
学者接受人类健康和疾病相关研究方面的教育;3)
由科学和临床专家共同指导的论文/博士后研究项目。
培训计划的评估将使用相关的、经过验证的评估工具,例如团队合作
UTMB 承诺提供能力测试和其他主要财务资源、空间和人员。
该培训核心的监督、关键核心资源、综合计划和研讨会。
基础科学学院还为培训核心提供财政和基础设施支持。
UTMB 教务长的支持信列举了当前和未来对 ITS 的承诺,其中
确保这个监督实体对我们的创新培训计划取得成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK R HELLMICH其他文献
MARK R HELLMICH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK R HELLMICH', 18)}}的其他基金
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
新型 CCK-B/胃泌素受体剪接变体的研究
- 批准号:
6635297 - 财政年份:2001
- 资助金额:
$ 26.18万 - 项目类别:
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
新型 CCK-B/胃泌素受体剪接变体的研究
- 批准号:
6332317 - 财政年份:2001
- 资助金额:
$ 26.18万 - 项目类别:
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
新型 CCK-B/胃泌素受体剪接变体的研究
- 批准号:
6896603 - 财政年份:2001
- 资助金额:
$ 26.18万 - 项目类别:
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
新型 CCK-B/胃泌素受体剪接变体的研究
- 批准号:
6517796 - 财政年份:2001
- 资助金额:
$ 26.18万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Developing an oral health screening tool for an integrated model of care to reduce treatment-related oral morbidity in head and neck cancer survivor
开发口腔健康筛查工具,用于综合护理模式,以减少头颈癌幸存者与治疗相关的口腔发病率
- 批准号:
10781183 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别:
GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management
GARDE:个性化癌症风险管理的可扩展临床决策支持
- 批准号:
10741231 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别:
An Intervention to Reduce Cancer Associated Thrombosis Through Improved Prophylaxis
通过改进预防来减少癌症相关血栓形成的干预措施
- 批准号:
10723791 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别:
Mixed methods examination of warning signs within 24 hours of suicide attempt in hospitalized adults
住院成人自杀未遂 24 小时内警告信号的混合方法检查
- 批准号:
10710712 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别:
Multi-site Community Oncology Planning for the CONNECT Intervention Targeting Lung Cancer Caregivers
针对肺癌护理人员的 CONNECT 干预措施的多站点社区肿瘤学规划
- 批准号:
10730680 - 财政年份:2023
- 资助金额:
$ 26.18万 - 项目类别: